Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peripheral nerve CR1 limit complement-mediated haemolysis.

C A Vedeler1, R Matre

  • 1Broegelmann Research Laboratory for Microbiology, Bergen, Norway.

Journal of Neuroimmunology
|November 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Limbic Encephalitis following Allogeneic Hematopoietic Stem Cell Transplantation.

Case reports in immunology·2022
Same author

Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity.

Neuropathology and applied neurobiology·2018
Same author

Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy.

European journal of neurology·2017
Same author

CCDC104 Antibodies and Mitosis of Cancer Cells.

Scandinavian journal of immunology·2017
Same author

Assays for Infliximab Drug Levels and Antibodies: A Matter of Scales and Categories.

Scandinavian journal of immunology·2017
Same author

Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.

Journal of neurology·2016
Same journal

Spinal cord microglia exhibit a dysfunctional response to myelin damage.

Journal of neuroimmunology·2026
Same journal

Methodological concerns in the cutoff determination of a flow cytometric MOG-IgG assay: The need for independent validation.

Journal of neuroimmunology·2026
Same journal

Clinical features, imaging findings, and treatment outcomes of optic neuritis associated with anti-CRMP5 antibodies: a systematic review.

Journal of neuroimmunology·2026
Same journal

Serum IDO1 and β-catenin levels in patients with multiple sclerosis with and without atherosclerosis: A case-control study.

Journal of neuroimmunology·2026
Same journal

Neurological sequelae of Long COVID: Pathophysiological mechanisms, diagnostic advances, and therapeutic perspectives.

Journal of neuroimmunology·2026
Same journal

Corrigendum to 'Role of CD40 in prion disease and the immune response to recombinant PrP' [Journal of Neuroimmunology 257 (2013) 21-27/475655].

Journal of neuroimmunology·2026
See all related articles

Complement receptor 1 (CR1) purified from peripheral nerves inhibits complement-mediated cell lysis. This finding suggests CR1 on Schwann cells may protect nerve tissue from immune damage in vivo.

Area of Science:

  • Immunology
  • Neuroscience
  • Cell Biology

Background:

  • Complement receptor 1 (CR1) is a key regulator of the complement system.
  • The role of CR1 in peripheral nerve tissue is not well understood.

Purpose of the Study:

  • To investigate the presence and function of CR1 in peripheral nerve extracts.
  • To determine if CR1 from peripheral nerves can inhibit complement-mediated lysis.

Main Methods:

  • Purification of CR1 from sciatic nerve extracts using monoclonal antibody affinity chromatography.
  • Assay of CR1's effect on complement-mediated hemolysis of sheep erythrocytes.
  • Validation of CR1's inhibitory activity using specific antibodies.

Main Results:

Related Experiment Videos

  • Purified peripheral nerve CR1 demonstrated a dose-dependent inhibition of complement-mediated hemolysis.
  • Control substances lacking CR1 did not inhibit hemolysis.
  • An anti-CR1 antibody abolished the inhibitory effect, confirming CR1's role.

Conclusions:

  • Peripheral nerve CR1 possesses functional activity, inhibiting complement-mediated lysis.
  • CR1 expressed on Schwann cells may play a protective role in vivo by preventing terminal complement complex formation and subsequent nerve damage.